News
Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...
The FDA does not plan a reorganization of the agency but will consolidate offices that handle travel and IT ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. Gilead Sciences agreed to pay $202 million to settle ...
"Hopefully his brutality would be even more intense because of his kindness," says the 'Good Wife' star of his dark turn in ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results